Recognizing Telomere Biology Disorders in Familial Pulmonary Fibrosis
Clinician's RoundtableRecognizing Telomere Biology Disorders in Familial Pulmonary Fibrosis
Pilar Rivera-Ortega, MD
Precision Medicine in Fibrotic ILD: Predicting Risk and Treatment Response
Clinician's RoundtablePrecision Medicine in Fibrotic ILD: Predicting Risk and Treatment Response
Pilar Rivera-Ortega, MD
Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Project Oncology®Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Project Oncology®A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Geoffrey Oxnard, MD
Integrating Molecular Testing into NSCLC Care
Project Oncology®Integrating Molecular Testing into NSCLC Care
Geoffrey Oxnard, MD
- advertisement
- 3 questions
- advertisement
Beyond the Flu: Safeguarding Older Adults Through Vaccination
VacciNationBeyond the Flu: Safeguarding Older Adults Through Vaccination
Jennifer Caudle, DO, FACOFP
Stephen Thomas, MD
Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
Medical Industry FeatureImmune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
- Asthma CSI: Behind the Cytokine Curtain, Part 1: Asthma HQMedical Industry FeatureAsthma CSI: Behind the Cytokine Curtain, Part 1: Asthma HQ
- 09/22/2026
- 09/22/2026
- 09/22/2026
- 09/17/2026
- 09/16/2026
- 09/15/2026